Skip to main content
. 2010 May 21;2:19. doi: 10.3389/fnagi.2010.00019

Table 3.

Double-blind, randomized, placebo-controlled trials of NSAIDs in patients with MCI.

Drug Treatment duration Dose (mg/day) No. patients Main outcome Reference
Rofecoxib 4 years 25 1,457 Detrimental effects Thal et al. (2005)
Triflusal 13 months 900 257 Neutral/beneficial effects Gómez-Isla et al. (2008)
Celecoxib 18 months 200–400 88* Beneficial effects Small et al. (2008)

*Subjects with age-associated memory decline.